Skip to main content
Log in

Myasthenia gravis outcome measure: development and validation of a disease-specific self-administered questionnaire

  • ORIGINAL
  • Published:
Neurological Sciences Aims and scope Submit manuscript

Abstract.

We describe the development and validation of an outcome measure for patients with myasthenia gravis (MG) and show the correlation of the items with conventional MG measurements. In stage I, item generation, a group of methodologists, clinical experts generated a list of 56 items. The list was based on (1) a previous study on an MG sample, (2) clinical experience and (3) items proposed by MG patients. In stage 2, reduction of items, the list was reduced on the basis of results from field testing (41 patients completed the 56-item questionnaire). In stage 3, reliability and validity were assessed. A 25-item MG questionnaire (MGQ) was generated. Results were related to conventional measures of MG severity. Furthermore, the MGQ appeared reliable, sensitive and reproducible. The questionnaire was validated as an outcome measure.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

Author information

Authors and Affiliations

Authors

Additional information

Received: 21 October 2001 / Accepted in revised form: 13 March 2002

Rights and permissions

Reprints and permissions

About this article

Cite this article

Padua, L., Evoli, A., Aprile, I. et al. Myasthenia gravis outcome measure: development and validation of a disease-specific self-administered questionnaire. Neurol Sci 23, 59–68 (2002). https://doi.org/10.1007/s100720200027

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s100720200027

Navigation